Headlands Technologies LLC Insulet Corp Transaction History

Headlands Technologies LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$161.02 - $206.98 $201,758 - $259,345	1,253 Added 66.93%	3,125 $630,000
Q1 2024 May 07, 2024	BUY	$163.6 - $209.11 $241,637 - $308,855	1,477 Added 373.92%	1,872 $320,000
Q4 2023 Feb 02, 2024	BUY	$127.77 - $221.42 $50,469 - $87,460	395 New	395 $85,000

685

62.7M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Headlands Technologies LLC with notifications on news.